Sinocare Pays $200 Million for Second US Diabetes Monitoring Device Company

Sinocare of Shangsha will pay up to $200 million to acquire PTS Diagnostics of Indianapolis, a company that makes point-of-care blood testing devices. PTS make devices that test glucose, lipid or nicotine levels in the blood. The PTS transaction is Sinocare's second purchase of a US company in six months. In November 2015, Sinocare paid $273 million for Nipro Diagnostics of Florida, the US division of Japan's Nipro, which also makes glucose monitoring products. In China, Sinocare is in the biosensors business, including diabetes monitoring devices. More details. . . . Stock Symbol: (SHZ: 300298) Share this with colleagues: // //